Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2016 call → NOWe need to determine if management's forward account is substantially about narrating what its counterparties are doing and scaling, with the company already inside that growth, and the trajectory early and large relative to the company. Let's analyze the transcript. The call is about Enterprise Financial Services Corp. Management discusses loan growth, deposits, fee income, etc. They talk about their own strategies, market conditions, and some specific segments like EVL (life insurance premium finance) and tax credit brokerage. They mention that EVL growth was softer in Q4 due to pricing competition and M&A transaction momentum tapering. They talk about adding new sponsors and expanding referral sources. They also mention deposit growth and creating a Director of Deposits position. They discuss the Jefferson County Bancshares acquisition. The question asks: does management explain where the company's business is going by narrating what its counterparties are themselves doing and scaling? That is, does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? We need to see if management speaks about identifiable counterparties' business as part of its own, with the company already inside that growth, and the trajectory early and large. Looking at the transcript: Management talks about loan growth in various markets, but that's their own lending. They talk about C&I and CRE growth. They mention specific industries like healthcare, urban core, intermodal, logistics. But they don't describe specific counterparties' own expansion plans as the driver. They talk about their own calling efforts, recruiting bankers, etc. They mention EVL (life insurance premium finance) and that they are adding more sponsors to their pool. But they don't describe those sponsors' own trajectories. They mention that M&A transaction momentum tapered off, and they are weathering pricing competition. That's not a narrative of counterparties scaling. They mention tax credit brokerage seasonal upswing. Not a counterparty trajectory.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.